HDAC6 and ciliopathy: Similarly, its role in regulating primary cilia disassembly may envisage HDAC6 as a molecular target for the treatment of ciliopathies, a family of diseases presenting both genotypic and phenotypic heterogeneity, primarily affecting the CNS [83,84].